Sandbox:Reddy 2: Difference between revisions

Jump to navigation Jump to search
(Blanked the page)
No edit summary
Line 1: Line 1:
Hospitalized patients
{| class="wikitable"
!Infection
!
!Organisms
!First DOC
!Alternative
!
|-
| rowspan="2" |'''Osteomyelitis'''
|Presumed hematogenous source or contiguous without vascular insufficiency
|''S. aureus''
|Vancomycin
|Vanc
|If ''S. aureus'' is methicillin-susceptible then cefazolin 2 g IV q8h or nafcillin 2 g IV q4h are the antibiotics of choice.
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if blood cultures are negative and patient clinically stable.
|-
|With vascular insufficiency or diabetes mellitus (e.g. severe diabetic foot ulcer)
|''S. aureus'' 
Enterobacteriaceae


Anaerobes
|'''Vancomycin'''
PLUS ONE OF:
'''Piperacillin/Tazobactam'''ID-R: SFGH 4.5 g IV q6-8h
OR
'''Ertapenem''' 1 g IV daily
|For '''severe''' PCN allergy:
'''Vancomycin'''
PLUS ONE OF:
'''Ciprofloxacin'''ID-R: VASF 400 mg IV q12h
OR
'''Levofloxacin''' ID-R: VASF 750 mg IV daily
OR
'''Aztreonam''' ID-R: SFGH 2 g IV q8h
ALL WITH OR WITHOUT:
'''Metronidazole'''500 mg IV q8h (if patient critically ill)
|Other organisms are possible, esp. with hardware microbiologic diagnosis and ID consultation recommended
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if patient clinically stable
Once stable, switch to oral antibiotics based on susceptibility results.
|-
|'''Septic Arthritis'''
|
|''S. aureus''
''Streptococci spp.''
''N. gonorrhoeae''
''Enterobacteriaceae (rarely)''
|'''Vancomycin'''
PLUS
'''Ceftriaxone'''1 g IV daily
|For '''severe''' PCN allergy:
'''Vancomycin'''
PLUS ONE OF:
'''Ciprofloxacin'''ID-R: VASF 400 mg IV q12h
OR
'''Levofloxacin''' ID-R: VASF 500 mg IV daily
OR
'''Aztreonam'''ID-R: SFGH 2 g IV q8h if gonococcus is strongly suspected
|Gram stain recommended to guide therapy.
Narrow coverage to microbiologically confirmed pathogens.
|}

Revision as of 18:56, 29 June 2017

Hospitalized patients

Infection Organisms First DOC Alternative
Osteomyelitis Presumed hematogenous source or contiguous without vascular insufficiency S. aureus Vancomycin Vanc If S. aureus is methicillin-susceptible then cefazolin 2 g IV q8h or nafcillin 2 g IV q4h are the antibiotics of choice.

Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if blood cultures are negative and patient clinically stable.

With vascular insufficiency or diabetes mellitus (e.g. severe diabetic foot ulcer) S. aureus 

Enterobacteriaceae

Anaerobes

Vancomycin

PLUS ONE OF:

Piperacillin/TazobactamID-R: SFGH 4.5 g IV q6-8h

OR

Ertapenem 1 g IV daily

For severe PCN allergy:

Vancomycin

PLUS ONE OF:

CiprofloxacinID-R: VASF 400 mg IV q12h

OR

Levofloxacin ID-R: VASF 750 mg IV daily

OR

Aztreonam ID-R: SFGH 2 g IV q8h

ALL WITH OR WITHOUT:

Metronidazole500 mg IV q8h (if patient critically ill)

Other organisms are possible, esp. with hardware microbiologic diagnosis and ID consultation recommended

Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if patient clinically stable

Once stable, switch to oral antibiotics based on susceptibility results.

Septic Arthritis S. aureus

Streptococci spp.

N. gonorrhoeae

Enterobacteriaceae (rarely)

Vancomycin

PLUS

Ceftriaxone1 g IV daily

For severe PCN allergy:

Vancomycin

PLUS ONE OF:

CiprofloxacinID-R: VASF 400 mg IV q12h

OR

Levofloxacin ID-R: VASF 500 mg IV daily

OR

AztreonamID-R: SFGH 2 g IV q8h if gonococcus is strongly suspected

Gram stain recommended to guide therapy.

Narrow coverage to microbiologically confirmed pathogens.